The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bajtay, Z.
Right arrow Articles by Dierich, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bajtay, Z.
Right arrow Articles by Dierich, M. P.
The Journal of Immunology, 2004, 173: 4775-4778.
Copyright © 2004 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Productive HIV-1 Infection of Dendritic Cells via Complement Receptor Type 3 (CR3, CD11b/CD18)

Zsuzsa Bajtay*, Cornelia Speth*, Anna Erdei{dagger} and Manfred P. Dierich1,*

* Department of Hygiene, Microbiology and Social Medicine, Innsbruck Medical University and Ludwig-Boltzman-Institute for AIDS Research, Innsbruck, Austria; and {dagger} Department of Immunology and Research Group of the Hungarian Academy of Sciences, Eötvös Loránd University, Budapest, Hungary

In the present study, we demonstrate that macrophage-tropic HIV-1 opsonized by complement and limited amounts of anti-HIV-IgG causes up to 10-fold higher productive infection of human monocyte-derived dendritic cells than HIV treated with medium or HIV opsonized by Ab only. Enhanced infection is completely abolished by a mAb specific for the ligand-binding site of CD11b (i.e., {alpha}-chain of complement receptor 3, receptor for iC3b), proving the importance of complement receptor 3 in this process. Inhibition of complement activation by EDTA also prevents enhanced infection, further demonstrating the role of complement in virus uptake and productive infection. Since HIV is, even in the absence of Abs, regularly opsonized by complement, most probably the above-described mechanism plays a role during in vivo primary infection.




This article has been cited by other articles:


Home page
J. Virol.Home page
T. E. Morrison, J. D. Simmons, and M. T. Heise
Complement Receptor 3 Promotes Severe Ross River Virus-Induced Disease
J. Virol., November 15, 2008; 82(22): 11263 - 11272.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Huber, V. von Wyl, C. G. Ammann, H. Kuster, G. Stiegler, H. Katinger, R. Weber, M. Fischer, H. Stoiber, H. F. Gunthard, et al.
Potent Human Immunodeficiency Virus-Neutralizing and Complement Lysis Activities of Antibodies Are Not Obligatorily Linked
J. Virol., April 15, 2008; 82(8): 3834 - 3842.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Wilflingseder, Z. Banki, E. Garcia, M. Pruenster, G. Pfister, B. Muellauer, D. S. Nikolic, C. Gassner, C. G. Ammann, M. P. Dierich, et al.
IgG Opsonization of HIV Impedes Provirus Formation in and Infection of Dendritic Cells and Subsequent Long-Term Transfer to T Cells
J. Immunol., June 15, 2007; 178(12): 7840 - 7848.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Bouhlal, N. Chomont, M. Requena, N. Nasreddine, H. Saidi, J. Legoff, M. D. Kazatchkine, L. Belec, and H. Hocini
Opsonization of HIV with Complement Enhances Infection of Dendritic Cells and Viral Transfer to CD4 T Cells in a CR3 and DC-SIGN-Dependent Manner
J. Immunol., January 15, 2007; 178(2): 1086 - 1095.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Banki, D. Wilflingseder, C. G. Ammann, M. Pruenster, B. Mullauer, K. Hollander, M. Meyer, G. M. Sprinzl, J. van Lunzen, H.-J. Stellbrink, et al.
Factor I-Mediated Processing of Complement Fragments on HIV Immune Complexes Targets HIV to CR2-Expressing B Cells and Facilitates B Cell-Mediated Transmission of Opsonized HIV to T Cells.
J. Immunol., September 1, 2006; 177(5): 3469 - 3476.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. M. I. Aasa-Chapman, S. Holuigue, K. Aubin, M. Wong, N. A. Jones, D. Cornforth, P. Pellegrino, P. Newton, I. Williams, P. Borrow, et al.
Detection of Antibody-Dependent Complement-Mediated Inactivation of both Autologous and Heterologous Virus in Primary Human Immunodeficiency Virus Type 1 Infection
J. Virol., March 1, 2005; 79(5): 2823 - 2830.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. R. Greaves and S. Gordon
Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors
J. Lipid Res., January 1, 2005; 46(1): 11 - 20.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.